Skip to main content
SpringerLink
Log in

The Respiratory Distress Syndrome in Adults with Gram-negative Sepsis

  • Conference paper
Update 1991

Part of the book series: Update in Intensive Care and Emergency Medicine ((UICM,volume 14))

  • 109 Accesses

Abstract

During the past 40 years, essentially since the introduction of antibiotics, the incidence of gram-negative bacteremia has risen dramatically [1, 2], increasing from 7 episodes per 1000 hospital admissions in 1965 to 13 episodes per 1000 admissions in 1974 [3]. It is estimated that 70000 to 300000 cases occur annually [4, 5]. In a variety of studies [2, 3, 6–19], the crude mortality is reported to be in the range of 25% to 50%, while the attributable mortality is estimated to be 25% to 32% [4, 5, 14, 20]. Mortality rates increase in patients in whom gram-negative bacteremia leads to shock. This complication develops in approximately 40% of bacteremic patients and results in reported mortality rates of 40% to 77% [9, 18].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Weinstein L (1985) Gram-negative bacterial infections: A look at the past, a view of the present, and a glance at the future. Rev Infect Dis 7 (Suppl 4):S538–S544

    Article  PubMed  Google Scholar 

  2. McGowan JE Jr, Barnes MW, Finland M (1975) Bacteremia at Boston City Hospital: Occurrence and mortality during 12 selected years (1935–1972), with special reference to hospital-acquired cases. J Infect Dis 132:316–334

    Article  PubMed  Google Scholar 

  3. Kreger BE, Craven DE, Carling PC, McCabe WR (1980) Gram-negative bacteremia. III. Reassessment of etiology, epidemiology and ecology in 612 patients. Am J Med 68:332–343

    Article  PubMed  CAS  Google Scholar 

  4. Wolff SM, Bennett JV (1974) Gram-negative rod bacteremia. N Engl J Med 291:733–734

    Article  PubMed  CAS  Google Scholar 

  5. Wenzel RP (1988) The mortality of hospital-acquired bloodstream infections: need for a new vital statistic? International J Epidemiol 17:225–227

    Article  CAS  Google Scholar 

  6. Young LS (1987) Gram-negative sepsis. In: Mandell GL, Douglas RG Jr, Bennett JE (eds) Principles and practice in infectious diseases. Churchill Livingstone, New York, pp 611–636

    Google Scholar 

  7. Hinshaw L, Peduzzi P, Young E (1987) Effect of high dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis. N Engl J Med 317:659–665

    Article  Google Scholar 

  8. Bone RC, Fisher CJ Jr, Clemmer TP, Slotman GJ, Metz CA, Balk RA (1987) The methyl-prednisolone severe sepsis study group. A controlled clinical trial of high-dose methylpred-nisolone in treatment of severe sepsis and septic shock. N Engl J Med 317:653–658

    Article  PubMed  CAS  Google Scholar 

  9. Ziegler EJ, McCutchan JA, Fierer J, Glauser MP, Sadoff JC, Douglas H, Braude AI (1987) Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli. N Engl J Med 307:1225–1230

    Article  Google Scholar 

  10. McCabe WR, Jackson GG (1962) Gram-negative bacteremia. I. Etiology and ecology. Arch Intern Med 110:847–855

    Article  Google Scholar 

  11. McCabe WR, Jackson GG (1962) Gram-negative bacteremia. I. Clinical, laboratory and therapeutic observations. Arch Intern Med 110:856–864

    Article  Google Scholar 

  12. DuPont HL, Soink WW (1966) Infections due to gram-negative organisms: An analysis of 860 patients with bacteremia at the University of Minnesota Medical Center, 1958–1966. Medicine 48:327–332

    Google Scholar 

  13. Bryant RE, Hood AF, Hood CE, Koenig MG (1971) Factors affecting mortality of gram-negative rod bacteremia. Arch Intern Med 127:120–128

    Article  PubMed  CAS  Google Scholar 

  14. Myerowitz RL, Madeiros AA, O’Brien TF (1971) Recent experience with bacillemia due to gram-negative organisms. J Infect Dis 124:239–256

    Article  PubMed  CAS  Google Scholar 

  15. Spengler RF, Geenough WB III, Stolley PD (1978) A descriptive study of nosocomial bacteremias at The Johns Hopkins Hospital, 1968–1974. Johns Hopkins Medical Journal 142:77–84

    PubMed  CAS  Google Scholar 

  16. Kreger BE, Craven DE, McCabe WR (1980) Gram-negative bacteremia IV. Re-evaluation of clinical features and treatment in 612 patients. Am J Med 68:344–355

    Article  PubMed  CAS  Google Scholar 

  17. Bryan CS, Reynolds KL, Brenner ER (1983) Analysis of 1186 episodes of gram-negative bacteremia in non-university hospitals : the effects of antimicrobial therapy. Rev Infect Dis 5:629–638

    Article  PubMed  CAS  Google Scholar 

  18. Sprung CL, Caralis PV, Marcial EH, et al. (1984) The effects of high-dose corticosteroids in patients with septic shock. A prospective, controlled study. N Engl J Med 311:1137–1143

    Article  PubMed  CAS  Google Scholar 

  19. Fried MA, Vosti KL (1968) The importance of underlying disease in patients with gram-negative bacteremia. Arch Intern Med 121:418–423

    Article  Google Scholar 

  20. Setia U, Gross PA (1977) Bacteremia in a community hospital: spectrum and mortality. Arch Intern Med 137:1698–1701

    Article  PubMed  CAS  Google Scholar 

  21. Martin CM, Cuomo AJ, Geraaghty MJ, Zager JR, Mandes TC (1969) Gram-negative rod bacteremia. J Infect Dis 119:506–517

    Article  PubMed  CAS  Google Scholar 

  22. Said SI, Foda HD (1989) Pharmacologic modulation of lung injury. Am Rev Respir Dis 139:1553–1564

    PubMed  CAS  Google Scholar 

  23. Tracey KJ, Beutler B, Lowry SF, et al. (1986) Shock and tissue injury induced by recombinant human cachectin. Science 234:470–474

    Article  PubMed  CAS  Google Scholar 

  24. Goldblum SE, Sun WL (1990) Tumor necrosis factor-alpha augments pulmonary arterial transendothelial albumin flux in vitro. Am J Physiol 258(2):L 57–67

    CAS  Google Scholar 

  25. Meyrick BO, Ryan US, Brigham KL (1986) Direct effects of E. coli endotoxin on structure and permeability of pulmonary endothelial monolayers and the endothelial layer of intimai explants. Am J Pathol 122:140–151

    PubMed  CAS  Google Scholar 

  26. Hammerschmidt DE, Weaver LJ, Hudson LD, Craddock PR, Jacob HS (1980) Association of complement activation and elevated plasma-C5a with adult respiratory distress syndrome: pathophysiological relevance and possible prognostic value. Lancet 1:947–949

    Article  PubMed  CAS  Google Scholar 

  27. Jacob HS (1980) Role of complement and granulocytes in septic shock. Acta Chir Scand (Suppl) 499:97–106

    CAS  Google Scholar 

  28. Bachofen M, Weibel ER (1977) Alterations of the gas exchange apparatus in adult respiratory insufficiency associated with septicemia. Am Rev Resp Dis 116:589–615

    PubMed  CAS  Google Scholar 

  29. Immerman GA, Renzetti AD, Hill HR (1983) Functional and metabolic activity of granulocytes from patients with adult respiratory distress syndrome: evidence for activated neutrophils in the pulmonary circulation. Am Rev Respir Dis 127:290–300

    Google Scholar 

  30. Tate RM, Repine JE (1983) Neutrophils and the adult respiratory distress syndrome. Am Rev Respir Dis 128:552–559

    PubMed  CAS  Google Scholar 

  31. Swank DW, Moore SB (1989) Roles of the neutrophil and other mediators in the adult respiratory distress syndrome. Mayo Clin Proc 64:1118–1132

    PubMed  CAS  Google Scholar 

  32. Kaplan RL, Sahn SA, Petty TL (1979) Incidence and outcome of the respiratory distress syndrome in gram-negative sepsis. Arch Intern Med 139:867–869

    Article  PubMed  CAS  Google Scholar 

  33. Martin MA, Wenzel RP, Gorelick KJ, and the Xoma Sepsis Study Group (1990) Prospective U.S. study of gram-negative bacterial sepsis-natural history in the 1980s. Circ Shock 31:245 (abstract)

    Google Scholar 

  34. Michel O, Duchateau J, Sergysels R (1989) Effect of inhaled endotoxin on bronchial reactivity in asthmatic and normal subjects. J Appl Physiol 66:1059–1064

    PubMed  CAS  Google Scholar 

  35. Ashbaugh DG, Bigelow DB, Petty TL, Levine BE (1967) Acute respiratory distress in adults. Lancet 2:319–323

    Article  PubMed  CAS  Google Scholar 

  36. Petty TL, Ashbaugh DG (1971) The adult respiratory distress syndrome. Clinical features, factors influencing prognosis and principles of management. Chest 60:233–239

    Article  PubMed  CAS  Google Scholar 

  37. Pepe PE, Potkin RT, Reus DH, Hudson LD, Canica CJ (1982) Clinical predictors of the adult respiratory distress syndrome. Am J Surg 144:124–130

    Article  PubMed  CAS  Google Scholar 

  38. Clowes GHA Jr (1974) Pulmonary abnormalities in sepsis. Surg Clin North Am 54:993–1013

    PubMed  Google Scholar 

  39. Montgomery AB, Stager MA, Carrico CJ, Hudson LD (1985) Causes of mortality in patients with the adult respiratory distress syndrome. Am Rev Respir Dis 132:485–489

    PubMed  CAS  Google Scholar 

  40. Fein AM, Lippmann M, Holtzman H, Eliraz A, Goldberg SK (1983) The risk factors, incidence, and prognosis of ARDS following septicemia. Chest 83:40–42

    Article  PubMed  CAS  Google Scholar 

  41. Bell RC, Coalson JJ, Smith JD, Johanson WG (1983) Multiple organ system failure and infection in adult respiratory distress syndrome. Ann Intern Med 99:293–298

    PubMed  CAS  Google Scholar 

  42. Bone RC, Fisher CJ Jr, Clemmer TP, Slotman GJ, Metz CA, Balk RA, the Methylpredniso-lone Severe Sepsis Study Group (1989) Sepsis syndrome: A valid clinical entity. Crit Care Med 17:389–393

    Article  PubMed  CAS  Google Scholar 

  43. Shenep JL, Mogan KA (1984) Kinetics of endotoxin release during antibiotic therapy for experimental gram-negative bacterial sepsis. J Infect Dis 150:380–388

    Article  PubMed  CAS  Google Scholar 

  44. Hopewell PC, Murray JF (1976) The adult respiratory distress syndrome. Annu Rev Med 27:343–356

    Article  PubMed  CAS  Google Scholar 

  45. Springer RP, Stevens PM (1979) The influence of PEEP on survival of patients in respiratory failure. Am J Med 66:196–200

    Article  PubMed  CAS  Google Scholar 

  46. Zapol WM, Snyder MT, Hill DH, et al. (1979) Extracorporeal membrane oxygenation in severe acute respiratory failure. A randomized prospective study. JAMA 242:2193–2196

    Article  PubMed  CAS  Google Scholar 

  47. The Veterans Administration Systemic Sepsis Cooperative Study Group (1987) Effects of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis. N Engl J Med 317:659–665

    Article  Google Scholar 

  48. Luce JM, Montgomery AB, Marks JD, Turner J, Metz CA, Murray JF (1988) Ineffectiveness of high-dose methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock. Am Rev Respir Dis 138:62–68

    Article  PubMed  CAS  Google Scholar 

  49. Peters WP, Johnson MW, Friedman PA, et al. (1981) Pressor effect of naloxone in septic shock. Lancet 1:529

    Article  PubMed  CAS  Google Scholar 

  50. DeMaria A, Craven DE, Heffernan JJ, et al. (1985) Naloxone versus placebo in treatment of septic shock. Lancet i:1363–1365

    Article  Google Scholar 

  51. Shenep JL, Flynn PM, Barrett FF, Stidham GL, Westenkirchner DF (1988) Serial quantitation of endotoxemia and bacteremia during therapy for gram-negative bacterial sepsis. J Infect Dis 157:565–568

    Article  PubMed  CAS  Google Scholar 

  52. Braude AI, Ziegler EJ, Douglas H, McCutchan JA (1977) Antibody to cell wall glycolipid of gram-negative bacteria: Induction of immunity to bacteremia and endotoxemia. J Infect Dis 136(Suppl):S167–S173

    Article  PubMed  Google Scholar 

  53. McCabe WR, Kreger BE, Johns M (1972) Type-specific and cross-reactive antibodies in gram-negative bacteremia. N Engl J Med 287:261–267

    Article  PubMed  CAS  Google Scholar 

  54. Ziegler EJ (1988) Protective antibody to endotoxin core: The emperor’s new clothes? J Infect Dis 158:286–290

    Article  PubMed  CAS  Google Scholar 

  55. Baumgartner JD, McCutchan JA, Van Melle G, et al. (1985) Prevention of gram-negative shock and death in surgical patients by antibody to endotoxin core glycolipid. Lancet 2:59–63

    Article  PubMed  CAS  Google Scholar 

  56. Calandra T, Glauser MP, Schellekens J, Verhoef J, the Swiss-Dutch J5 Immunoglobulin Study Group (1988) Treatment of gram-negative septic shock with human IgG antibody to Escherichia coli J5: A prospective, double-blind, randomized trial. J Infect Dis 158:312–319

    Article  PubMed  CAS  Google Scholar 

  57. Harkonen S, Scannon P, Mischak RP, Spitier LE, Foxall C, Kennedy D, Greenberg R (1988) Phase I study of a murine monoclonal anti-lipid A antibody in bacteremic and non-bacteremic patients. Antimicrob Agents Chemother 32:710–716

    PubMed  CAS  Google Scholar 

  58. Scannon PJ (1989) Monoklonale Antikörper in der Therapie der gramnegativen Sepsis. In: Lawin P, Peter K, Mertes N, Mollman M (eds) Schriftenreihe Intensivmedizin Notfallmedizin Anästhesiologie, vol 71. Thieme, Stuttgart New York, pp 140–145

    Google Scholar 

  59. Greenberg RN, Wilson KM, Kennedy D, Dodds L, Gorelick K (1989) Safety and efficacy of two doses of Xomen™ E5 (monoclonal antibody E5) in reducing mortality of patients with suspected gram-negative sepsis. 29th Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, DC

    Google Scholar 

  60. Gorelick K, Jackobs R, Chmel H, et al. (1989) Efficacy results of a randomized multicenter trial of E5 antiendotoxin monoclonal antibody in patients with suspected gram-negative sepsis. 29th Interscience on Antimicrobial Agents and Chemotherapy, Washington, D.C., p 101

    Google Scholar 

  61. Stevens JH, O’Hanley P, Shapiro JM, Mihm FG, Satoh PS, Collins JA, Raffm TA (1986) Effects of anti-C5a antibodies on the adult respiratory distress syndrome in septic primates. J Clin Invest 77:1812–1816

    Article  PubMed  CAS  Google Scholar 

  62. Mandell GL (1988) ARDS, neutrophils, and pentoxifylline. Am Rev Respir Dis 138:1103–1105

    PubMed  CAS  Google Scholar 

  63. Brigham KL, Meyrick B (1986) Endotoxin and lung injury. Am Rev Respir Dis 133:913–927

    PubMed  CAS  Google Scholar 

  64. Klebanoff SJ, Clark RA (1978) The neutrophil — function and clinical disorders. North Holland Publishing Company, Amsterdam

    Google Scholar 

  65. Bellavite P (1988) The superoxide-forming enzymatic system of phagocytes. Free Rad Biol Med 4:225–261

    Article  PubMed  CAS  Google Scholar 

  66. Markowitz MM, Rozen P, Pero RW, Tobi M, Miller DG (1988) Hydrogen peroxide induced ADPRT response in patients with inflammatory bowel disease. Gut 29:1680–1686

    Article  PubMed  CAS  Google Scholar 

  67. Bernard G, Lucht W, Niedermeyer M, Snapper J, Ageltree M, Brigham K (1984) Effect of n-acetylcysteine on the pulmonary response to endotoxin in awake sheep and upon in vitro granulocyte function. J Clin Invest 73:1772–1784

    Article  PubMed  CAS  Google Scholar 

  68. Milligan SA, Hoeffel SA, Flick MR (1985) Endotoxin-induced acute lung injury in unanes-thetized sheep is prevented by catalase. Am Rev Respir Dis 131:A422 (abstract)

    Google Scholar 

  69. Snapper JR, Hutchison AA, Ogletree ML (1983) Effects of cyclooxygenase inhibitors on the alterations in lung mechanics caused by endotoxemia in the unaesthetized sheep. J Clin Invest 72:63–76

    Article  PubMed  CAS  Google Scholar 

  70. Winn R, Enerson B, Price S, Rice CL (1988) Indomethacin, but not dazoxiben, reduced lung fluid filtration after E. coli infusion. J Appl Physiol 64:2468–2473

    PubMed  CAS  Google Scholar 

  71. Borg T, Berdin B, Modig J (1985) Prophylactic and delayed treatment with indomethacin in a porcine model of early adult respiratory distress syndrome induced by endotoxaemia. Acta Anaesthesiol Scand 30:47–59

    Article  Google Scholar 

  72. Braquet P (1986) Proof of involvement of PAF in various immune disorders using BN 52021 (ginkgolide B): A powerful PAF antagonist isolated from Ginkgo biloba L. Adv Prostaglandin Thromboxane Leukotriene Res 16:179–198

    CAS  Google Scholar 

Download references

Authors
  1. M. A. Martin
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Intensive Care, Erasme Hospital, Free University of Brussels, Route de Lennik 808, B-1070, Brussels, Belgium

    Jean Louis Vincent (Clinical Director) (Clinical Director)

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Springer-Verlag Berlin, Heidelberg

About this paper

Cite this paper

Martin, M.A. (1991). The Respiratory Distress Syndrome in Adults with Gram-negative Sepsis. In: Vincent, J.L. (eds) Update 1991. Update in Intensive Care and Emergency Medicine, vol 14. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-84423-2_21

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-84423-2_21

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-53672-7

  • Online ISBN: 978-3-642-84423-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation